<DOC>
	<DOCNO>NCT00219310</DOCNO>
	<brief_summary>This trial ass whether RGH patient two recurrent episode within three month period would benefit suppressive treatment whether patient prefer episodic therapy suppressive therapy treatment RGH .</brief_summary>
	<brief_title>RELIEF : Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir</brief_title>
	<detailed_description />
	<mesh_term>Herpes Genitalis</mesh_term>
	<mesh_term>Famciclovir</mesh_term>
	<mesh_term>2-Aminopurine</mesh_term>
	<criteria>• Patients immunocompetent 4 episode Recurrent Genital Herpes ( RGH ) last 12 month . Patients active HSV2 HSV1 infection confirm Polymerase Chain Reaction ( PCR ) . Patients active symptom ( i.e. , itch , burning , tingle , ache , tenderness , rash pain ) associate recurrent episode genital herpes • Female patient pregnant breastfeeding . Current , history suspicion liver disease kidney disease . HIV infect ( confirm positive HIV serology ) . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Recurrent Genital Herpes ( RGH ) , famciclovir , episodic treatment , suppressive treatment , Polymerase Chain Reaction ( PCR ) .</keyword>
</DOC>